+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparison Between Different Strategies of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data From the PROVAR (Rheumatic Valve Disease Screening Program) Study



Comparison Between Different Strategies of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data From the PROVAR (Rheumatic Valve Disease Screening Program) Study



Journal of the American Heart Association 7(4)



Considering the limited accuracy of clinical examination for early diagnosis of rheumatic heart disease (RHD), echocardiography has emerged as an important epidemiological tool. The ideal setting for screening is yet to be defined. We aimed to evaluate the prevalence and pattern of latent RHD in schoolchildren (aged 5-18 years) and to compare effectiveness of screening between public schools, private schools, and primary care centers in Minas Gerais, Brazil. The PROVAR (Rheumatic Valve Disease Screening Program) study uses nonexperts and portable and handheld devices for RHD echocardiographic screening, with remote interpretation by telemedicine, according to the 2012 World Heart Federation criteria. Compliance with study consent and prevalence were compared between different screening settings, and variables associated with RHD were analyzed. In 26 months, 12 048 students were screened in 52 public schools (n=10 901), 2 private schools (n=589), and 3 primary care centers (n=558). Median age was 12.9 years, and 55.4% were girls. Overall RHD prevalence was 4.0% borderline (n=486) and 0.5% definite (n=63), with statistically similar rates between public schools (4.6%), private schools (3.5%), and primary care centers (4.8%) (P=0.24). The percentage of informed consents signed was higher in primary care centers (84.4%) and private schools (66.9%) compared with public schools (38.7%) (P<0.001). Prevalence was higher in children ≥12 years (5.3% versus 3.1%; P<0.001) and girls (4.9% versus 4.0%; P=0.02). Only age (odds ratio, 1.12; 95% confidence interval, 1.09-1.17; P<0.001) was independently associated with RHD. RHD screening in primary care centers seems to achieve higher coverage rates. Prevalence among schoolchildren is significantly high, with rates higher than expected in private schools of high-income areas. These data are important for the formulation of public policies to confront RHD.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055528561

Download citation: RISBibTeXText

PMID: 29444774

DOI: 10.1161/jaha.117.008039


Related references

Challenges for the Implementation of the First Large-Scale Rheumatic Heart Disease Screening Program in Brazil: The PROVAR Study Experience. Arquivos Brasileiros de Cardiologia 108(4): 370-374, 2017

Optimising echocardiographic screening for rheumatic heart disease in New Zealand: not all valve disease is rheumatic. Cardiology in the Young 21(4): 436-443, 2011

Echocardiographic prevalence of rheumatic heart disease in Brazilian schoolchildren: Data from the PROVAR study. International Journal of Cardiology 219: 439-445, 2017

Echocardiographic screening for rheumatic heart disease. Bulletin of the World Health Organization 86(2): 84, 2008

Echocardiographic screening for rheumatic heart disease. Circulation 129(19): 1912-1913, 2014

Rheumatic heart disease detected by echocardiographic screening. New England Journal of Medicine 357(20): 2088; Author Reply 2088-9, 2007

Echocardiographic screening for rheumatic heart disease: age matters. International Journal of Cardiology 168(2): 888-891, 2014

A rapid echocardiographic screening protocol for rheumatic heart disease in Samoa: a high prevalence of advanced disease. Cardiology in the Young 27(8): 1599-1605, 2018

Prevalence of rheumatic heart disease detected by echocardiographic screening. New England Journal of Medicine 357(5): 470-476, 2007

Echocardiographic Screening of Rheumatic Heart Disease in American Samoa. Pediatric Cardiology, 2017

Prevalence and prognostic value of echocardiographic screening for rheumatic heart disease. Open Heart 4(2): E000702, 2018

Prevalence of Rheumatic Heart Disease Detected by Echocardiographic Screening. Yearbook of Pediatrics 2009: 240-242, 2009

Handheld echocardiographic screening for rheumatic heart disease by non-experts. Heart 102(1): 35-39, 2016

Echocardiographic screening for rheumatic heart disease: issues for the cardiology community. Global Heart 8(3): 197-202, 2013

Echocardiographic screening for rheumatic heart disease-some answers, but questions remain. Translational Pediatrics 4(3): 206-209, 2016